Safety and efficacy of obinutuzumab with CHOP or bendamustine in previously untreated follicular lymphoma

The GAUDI study assessed safety and preliminary efficacy of induction therapy with obinutuzumab plus chemotherapy, followed by maintenance therapy with obinutuzumab alone, in previously untreated patients with follicular lymphoma. Assignment to chemotherapy was decided on a per-center basis before t...

Descripción completa

Detalles Bibliográficos
Autores principales: Grigg, Andrew, Dyer, Martin J.S., Díaz, Marcos González, Dreyling, Martin, Rule, Simon, Lei, Guiyuan, Knapp, Andrea, Wassner-Fritsch, Elisabeth, Marlton, Paula
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ferrata Storti Foundation 2017
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5395117/
https://www.ncbi.nlm.nih.gov/pubmed/28011903
http://dx.doi.org/10.3324/haematol.2016.152272

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5395117/
https://www.ncbi.nlm.nih.gov/pubmed/28011903
http://dx.doi.org/10.3324/haematol.2016.152272

Ejemplares similares